NeuroOne Medical Technologies Corporation (NMTC)

NASDAQ: NMTC · USD

$0.98

+0.05 (+4.8%)· Recorded snapshot

Market cap	8.9M
Revenue (ttm)	12.5M
Net income (ttm)	-7.4M
EPS (ttm)	-$0.95
Shares out	9.1M
Volume	18,976.276
Beta	0.90

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 12.5M
Net income (ttm): -7.4M
EPS (ttm): -$0.95
Market cap: 8.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-124.7

P25 -113.8P50 -46.5P75 -0.9

ROIC-79.5

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All NMTC indicators

Market & fundamental data

Available fields

206

Groups with data

Currency

USD

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001500198
Company name	NeuroOne Medical Technologies Corporation
Country	United States
Country code	US
CUSIP number	64130M308
Earnings date	2026-12-16
Earnings time	bmo
Employees	18
Employees change	1
Employees growth	5.88%
Enterprise value	$7.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	September
Founded	2009
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US64130M3088
Last 10-K release date	2025-12-17
Last earnings date	2026-08-13
Last refreshed	2026-11-04
Last stock split date	2026-04-16
Last stock split type	Reverse
Market cap	$8.9M
Market cap category	Nano-Cap
Next earnings date	2026-12-16
Options	Yes
Price	$0.98
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-11-03
Symbol	NMTC
U.S. state	Minnesota
Website	https://nmtc1.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-97.33%
EV/Sales	0.57x
FCF / EV yield	-101.56%
FCF yield	-80.25%
Forward EV/Sales	0.53x
Forward P/S	0.67x
Industry forward P/E	20.29x
Industry P/E	41.22x
P/B ratio	2.26x
P/S ratio	0.72x
Price / tangible book value	2.39x
Sector forward P/E	23.32x
Sector P/E	49.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-63.36%
EBITDA margin	-61.46%
Gross margin	23%
Operating margin	-63.36%
Pretax margin	-59.71%
Profit margin	-59.71%
Profit per employee	$-413,637
Revenue per employee	$692,706
ROA	-58.07%
ROA (5Y)	-75.09%
ROCE	-190.6%
ROE	-124.66%
ROE (5Y)	-188.79%
ROIC	-79.53%
SBC / revenue	11.33%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
Net income growth years	1
Revenue growth	88.09%
Revenue growth (Q)	16.34%
Revenue growth (QoQ)	-17.48%
Revenue growth 3Y	38.66%
Revenue growth 5Y	42.58%
Revenue growth quarters	2
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-109,536
Depreciation and amortization	$236,878
EBIT	$-7.9M
EBITDA	$-7.7M
EPS	$-0.95
FCF per share	$-0.79
Financing cash flow	$1.2M
Free cash flow	$-7.2M
Free cash flow minus SBC	$-8.6M
Gross profit	$2.9M
Investing cash flow	$-109,536
Net cash flow	$-6M
Net income	$-7.4M
Operating cash flow minus SBC	$-8.5M
Operating income	$-7.9M
Revenue	$12.5M
Stock-based compensation	$1.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-11.03
Book value per share	$0.43
Debt / equity	0.05
Long-term assets	$397,294
Long-term liabilities	$377,125
Net cash (debt)	$1.9M
Net cash / market cap	20.98%
Net cash growth	-75.82%
Net debt / equity	-0.5
Piotroski F-Score	3
Property, plant and equipment	$369,084
Shareholders' equity	$3.8M
Tangible book value	$3.7M
Tangible book value per share	$0.43
Total assets	$6.2M
Total cash	$2M
Total debt	$175,345
Total liabilities	$2.4M
WACC	9.02%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.47
Current assets	$5.8M
Current liabilities	$2M
Current ratio	2.84
Inventory turnover	4.58
Net working capital	$1.8M
Quick ratio	1.54
Working capital	$3.7M
Working capital turnover	2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-44.82%
Dividend yield	0%
Shareholder yield	-44.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$2.65
1D price change	4.84%
1M price change	-12.5%
1M total return	-12.5%
1W price change	15.31%
1W total return	15.31%
1Y price change	-79.38%
1Y return CAGR	-79.4%
1Y total return	-79.38%
20-day SMA	$0.98
200-day SMA	$3.16
3M price change	-42.01%
3M total return	-42.01%
3Y price change	-81.79%
3Y return CAGR	-43.31%
3Y total return	-81.79%
50-day SMA	$1.28
50-day SMA vs 200-day SMA	50under200
52-week high	$6.12
52-week high date	2026-01-06
52-week low	$0.77
52-week low date	2026-10-26
5Y price change	-94.17%
5Y return CAGR	-43.36%
5Y total return	-94.17%
6M price change	-77.47%
6M total return	-77.47%
After-hours change	2.03%
After-hours close	$0.98
After-hours price	$1.00
All-time high	$180.00
All-time high date	2018-08-21
All-time low	$0.77
All-time low date	2026-10-26
Average true range (ATR)	$0.11
Average volume	94.8K
Beta (1Y)	0.75
Beta (2Y)	1.48
Beta (5Y)	0.9
Change from 52-week high	-83.99%
Change from 52-week low	26.96%
Change from all-time high	-99.46%
Change from all-time low	26.96%
Change from open	1.68%
Day's gap	3.1%
Dollar volume	$18,597
High price	$1.00
Low price	$0.90
Monthly RSI	33.65
Open price	$0.96
Position in 52-week range	80.08%
Premarket change	2%
Premarket close	$0.98
Premarket price	$1.00
Premarket volume	252
Previous close	$0.93
Price vs 150-day SMA	-63%
Price vs 20-day SMA	-0.33%
Price vs 200-day SMA	-68.97%
Price vs 50-day SMA	-23.32%
Relative volume	0.2
RSI	44.28
Sharpe ratio	-1.52
Sharpe ratio (3Y)	-0.27
Sharpe ratio (5Y)	-0.07
Sortino ratio	-2.05
Sortino ratio (3Y)	-0.33
Sortino ratio (5Y)	-0.05
Volume	19K
Weekly RSI	25.66
YTD price change	-78.45%
YTD total return	-78.45%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6.3M
Float percentage	68.78%
Shares change (QoQ)	3%
Shares change (YoY)	44.82%
Shares held by insiders	31.22%
Shares held by institutions	28.8%
Shares outstanding	9.1M
Short % of float	3.31%
Short % of shares	2.28%
Short ratio	1.2 days

Deeper analysis on NMTC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NMTC report

Is a complete NMTC research report available?

No complete published report is available for NeuroOne Medical Technologies Corporation (NMTC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NeuroOne Medical Technologies Corporation (NMTC)

Price

Financial snapshot

Fair-value bridge

Latest news · NMTC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NMTC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NMTC

Frequently asked questions